scispace - formally typeset
D

Deyi Zheng

Researcher at Medical University of South Carolina

Publications -  17
Citations -  1572

Deyi Zheng is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Diabetes mellitus & Lipoprotein. The author has an hindex of 12, co-authored 17 publications receiving 1464 citations.

Papers
More filters
Journal ArticleDOI

Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance

TL;DR: It is concluded that insulin resistance had profound effects on lipoprotein size and subclass particle concentrations for VLDL, LDL, and HDL when measured by NMR; in type 2 diabetes, the lipop protein subclass alterations are moderately exacerbated but can be attributed primarily to the underlying insulin resistance.
Journal ArticleDOI

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

TL;DR: The data are consistent with a role for dyslipoproteinemia involving lipoprotein subclasses in the pathogenesis of diabetic retinopathy, and NMR-LSP reveals new associations between serum lipoproteins and severity ofretinopathy in type 1 diabetes.
Journal ArticleDOI

Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy

TL;DR: Potentially atherogenic lipoprotein profiles are associated with renal dysfunction in type 1 diabetes and further details are gained from NMR analysis.
Journal ArticleDOI

Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with gender and glycemia

TL;DR: Male gender and poor glycemia are associated with a potentially more atherogenic NMR lipoprotein profile and LDL susceptibility to in vitro oxidation in type 1 diabetes.
Journal ArticleDOI

Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.

TL;DR: It is demonstrated that modified LDL-IC present in circulation and/or tissues play an important pathogenic role in arteriosclerosis and has the same atherogenic and proinflammatory properties as IC prepared with human LDL and rabbit LDL antibodies.